Addex Therapeutics (ADXN) Debt by Year
Addex Therapeutics Ltd carried $0 in long-term debt against $2.1M in cash and equivalents at the end of fiscal year 2025. The change in long-term debt from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Addex Therapeutics Ltd has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ADXN Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ADXN Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Addex Therapeutics Ltd financials
Frequently Asked Questions
Addex Therapeutics Ltd carried $0 in long-term debt against $2.1M in cash and equivalents at the end of fiscal year 2025.
Addex Therapeutics Ltd (ADXN) reported $0 in long-term debt in fiscal year 2024 and $0 in long-term debt in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Addex Therapeutics Ltd (ADXN) reported $0 in long-term debt in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Addex Therapeutics Ltd (ADXN) reported on that line in every period on record.